Hypertriglyceridemia and hypercholesterolemia in human immunodeficiency virus-1-infected children treated with protease inhibitors

Archives of Medical Research

Volumn 37, Issue 1, 2006, Pages 129-132

  Solórzano Santos, Fortino ^a,b   Gochicoa Rangel, Laura G ^a   Palacios Saucedo, Gerardo ^a   Vázquez Rosales, Guillermo ^a   Miranda Novales, María Guadalupe ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b NONE   (Mexico)

Author keywords

Dyslipidemia and protease inhibitors; HIV infected children; Hypercholesterolemia and hypertriglyceridemia and HIV infected patients; Hypercholesterolemia in HIV infected children

Indexed keywords

CHOLESTEROL; LAMIVUDINE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; TRIACYLGLYCEROL; ZIDOVUDINE;

ADOLESCENT; ARTICLE; BODY FAT; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EXAMINATION; COHORT ANALYSIS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INFANT; LIPODYSTROPHY; MALE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INFANT; LAMIVUDINE; MALE; RITONAVIR; SAQUINAVIR; ZIDOVUDINE;

EID: 28444448414     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2005.05.013     Document Type: Article

References (25)

1. S.A. Rhone, R.S. Hogg, B. Yip, C. Sherlock, B. Conway, M.T. Schechter, M.V. O'Shaughnessy, and J.S. Montaner The antiviral effect of ritonavir and saquinavir in combination amongst HIV-infected adults: results from a community-based study AIDS 12 1998 619 624
2. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents Morb Mortal Wkly Rep 47 RR-5 1998 43 82
3. X. Saez-Llorens, and O. Ramilo Early experience with protease inhibitors in human immunodeficiency virus-infected children Pediatr Infect Dis J 17 1998 728 738
4. S. Mauss, J. Stechel, R. Willers, G. Schmutz, F. Berger, and W.O. Richter Differentiating hyperlipidemia associated with antiretroviral therapy AIDS 17 2003 189 194
5. G. Behrens, A. Dejam, H. Schmidt, H.J. Balks, G. Brabant, T. Korner, M. Stoll, and R.E. Schmidt Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patient under treatment with protease inhibitors AIDS 13 1999 F63 F70
6. S. Tsiodras, C. Mantzoros, S. Hammer, and M. Samore Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study Arch Intern Med 160 2000 2050 2056
7. A.K. Sullivan, N. Gazzard, and B.G. Gazzard Marked hypertriglyceridemia associated with ritonavir therapy AIDS 2 1998 1393 1394
8. U. Eriksson, M. Opravil, F.W. Amann, and A. Schaffner Is treatment with ritonavir a risk factor for myocardial infarction in HIV-infected patients? AIDS 12 1998 2079 2080
9. G. Behrens, H. Schmidt, D. Meyer, M. Stoll, and R.E. Schmidt Vascular complications associated with use of HIV protease inhibitors Lancet 351 1998 1958 1960
10. M.L. Green Evaluation and management of dyslipidemia in patients with HIV infection J Gen Intern Med 17 2002 797 810
11. S. Arpadi, P.A. Cuff, M. Horlick, and D.P. Kotler Visceral obesity, hypertriglyceridemia, and hypercortisolism in a boy with perinatally acquired HIV infection receiving protease inhibitor-containing antiviral treatment AIDS 13 1999 2312 2313
12. D. Jaquet, M. Levine, R.E. Ortega, A. Faye, M. Polak, E. Vilmer, and C. Levy-Marchal Clinical and metabolic presentation of lipodystrophic syndrome in HIV-infected children AIDS 14 2000 2123 2128
13. F.E. Babl, A.M. Reagan, and S.I. Pelton Abnormal body fat distribution in HIV-1 infected children on antiretrovirals Lancet 353 1999 1243 1244
14. R.A. Amaya, C.A. Kozinetz, A. McMeans, H. Schwarzwald, and M.W. Kline Lipodystrophy syndrome in human immunodeficiency virus-infected children Pediatr Infect Dis J 21 2002 405 410
15. G.C. Palacios, V.L. Palafox, M.M.T. Álvarez, G. Vázquez, G. Miranda, O. Muñoz, and F. Solórzano Response to two consecutive protease inhibitors combination therapy regimens in a cohort of HIV-1-infected children Scand J Infect Dis 34 2002 41 44
16. Centers for Disease Control and Prevention 1994 revised classification system for human immunodeficiency virus infection in children <13 years of age MMWR 43 RR12 1994 1 19
17. T. Starc, and R. Deckelbaum Evaluation of hypercholesterolemia in childhood Pediatr Rev 17 1996 94 97
18. G. Siberry, and R. Iannone The Harriet Lane Handbook 2000 Mosby St. Louis, MO
19. A. Bahar, U. Sevgican, F. Karademir, and I. Gocmen Serum cholesterol, triglyceride, VLDL-c, LDL-c and HDL-c levels in healthy children Tohoku J Exp Med 201 2003 75 80
20. K.L. Echevarria, T.C. Hardin, and J.A. Smith Hyperlipidemia associated with protease inhibitor therapy Ann Pharmacother 33 1999 859 863
21. R. Manfredi, and F. Chiodo Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate J Infect 42 2001 181 188
22. B.T. Roge, T.L. Katzenstein, and J. Gerstoft Comparison of P-triglyceride levels among patients with human immunodeficiency virus on randomized treatment with ritonavir, indinavir or ritonavir/saquinavir Scand J Infect Dis 33 2001 306 311
23. J.M. Lenhard, D.K. Croom, J.E. Weiel, and D.A. Winegar HIV protease inhibitors stimulate hepatic triglyceride synthesis Arterioscler Thromb Vasc Biol 20 2000 2625 2629
24. S. Safrin, and C. Grunfeld Fat distribution and metabolic changes in patients with HIV infection AIDS 13 1999 2493 2505
25. V. Mooser, and A. Carr Antiretroviral therapy-associated hyperlipidemia in HIV disease Curr Opin Lipidol 12 2001 313 319